ArticleScience translational medicine2019

A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.

Matthew T Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.